Scientific News Stryker, Boston Scientific Down As New Tariffs Impact Medtech Industry
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Stryker, Boston Scientific Down As New Tariffs Impact Medtech Industry is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific's Margins Strengthen in Q3: What's Driving It?
Boston Scientific BSX posted an adjusted gross margin of 71% in the third quarter of 2025, representing a 60-basis-point (bps) improvement compared to the prior-year period. The increase was mainly ... Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus